參考文獻 |
[1] Andersen, P.K. (1982). “Testing Goodness-of-Fit of Cox’s Regression and Life Model.” Biometrics, 38, 67-77.
[2] Breslow, N.E., Edler, L. and Berger, J. (1984). “A two-sample censored data rank test for acceleration.” Biometrics, 40, 1049-1062.
[3] Chen, Y.Q. and Jewell, N.P. (2001). “On a general class of semiparametric hazards regression models.” Biometrika B, 88, 687-702.
[4] Ciampi, A. and Etezadi-Amoli, J. (1985). “A general model for testing the proportional hazards and the accelerated failure time hypothesis in the analysis of censored survival data with covariate.” Communications
in Statistics, 14, 651-667.
[5] Cox, D.R. (1972). “Regression models and life-tables (with Discussion).” Journal of the Royal Statistical Society, Series B 34, 187-220.
[6] Cox, D.R. (1979). “A Note on the Graphical Analysis of Survival Data.” Biometrics, 66, 188-190.
[7] Cox, D.R. and Snell, E.J. (1968). “A General Definition of Residuals.” Journal of the Royal Statistical Society, Ser. B 30, 248-275.
[8] Chen, Y.Q. and Jewell, N.P. (2001). “On a general class of semiparametric hazards regression models.” Biometrika, 88, 687-702.
[9] Egger, M., Hirschel, B., Francioli, P. et al. (1997). “Impact of new antiretroviral combination therapies in HIV infected patients in Switzerland: prospective multicentre study.” Swiss HIV Cohort Study BMJ, 315(7117),
1194-9.
[10] Etezadi-Amoli, J. and Ciampi, A. (1987). “Extended hazard regression for censored survival data with covariates: A spline approximation for the baseline hazard function.” Biometrics, 43, 191-192.
[11] Grambsch, P.M. and Therneau, T.M. (1994). “Proportional hazards tests and diagnostics based on weighted residuals.” Biometrics, 81, 515-526.
[12] Gulick, R.M., Meibohm, A., Havlir, D., et al (2003). “Six-year follow-up of HIV-1-infected adults in a clinical trial of antiretroviral therapy with indinavir, zidovudine, and lamivudine.” AIDS, 17, 2345-2349.
[13] Henderson, R., Diggle, P. and Dobson, A. (2000). “Joint modeling of longitudinal measurements and event time data.” Biostatistics, 4, 465-480.
[14] Kaufmann, G.R., Perrink, L., Pantaleo, G., et al. (2003). “CD4 Tlymphocyte recovery in individuals with advanced HIV-1 infection receiving potent antiretroviral therapy for 4 years: the Swiss HIV Cohort Study.” Arch. Intern. Med., 163, 2187-2195.
[15] Kay, R. (1977). “Proportional Hazards Regression Models and the Analysis of Censored Survival Data.” Applied Statistics, 26, 227-237.
[16] Laird, N.M. and Ware, J.H. (1982). “Random-effects models for longitudinal data.” Biometrics, 38, 963-974.
[17] Lagakos, S.W. (1981). “The Graphical Evaluation of Explanatory Variables in Proportional Hazards Regression Models.”, Biometrika, 68, 93-98.
[18] Louis, T.A. (1991). “Nonparametric analysis of an accelerated failure time model.” Biometrika, 68, 381-390.
[19] Lucas, C.M., Chaisson, R.E. and Moore, R.D. (1999) “Highly active antiretroviral therapy in a large urban clinic: risk factors for virologic failure and adverse drug reactions.” Ann Intern Med, 131, 81-87.
[20] Miller, R.G. (1981). Survival Analysis. Wiley: New York.
[21] Moreau, T., O’Quigley, J. and Mesbah, M. (1985). “A Global Goodnessof-Fit Statistic for the Proportional Hazards Model.” Applied Statistics, 34, 212-218.
[22] O’Quigley, J. and Pessione, F. (1989). “Score Tests for Homogeneity of Regression Effect in the Proportional Hazards Model.” Biometrics, 45, 135-145.
[23] Palella, F.J., Delaney, K.M., Moorman, A.C., et al. (1998). “Declining morbidity and mortality among patients with advanced human immunod-eficiency virus infection. HIV Outpatient Study Investigators.” N Engl J Med., 338(13), 853-860.
[24] Pawitan, Y. and Self, S. (1993). “Modeling disease marker process in AIDS.” Journal of the American Statistical Association, 88, 719-726.
[25] Schoenfeld, D. (1980). “Chi-Squared Goodness-of-Fit Tests for the Proportional Hazards Regression Models.” Biometrika, 67, 145-153.
[26] Schoenfeld, D.A. (1982). “Partial residuals for the proportional hazards regression model.” Biometrika, 69, 239-241.
[27] Therneau, T.M. and Grambsch, P.M. (2000). Modeling Survival Data: Extending the Cox Model. Springer-Verlag.
[28] Tseng, Y.K., Hsieh, F. and Wang, J.L. (2005). “Joint modeling of accelerated failure time and longitudinal data.” Biometrika, 92, 587-603.
[29] Tsiatis, A.A., DeGruttola, V. and Wulfsohn, M.S. (1995). “Modeling the relationship of survival to longitudinal data measured with error. Applications to survival and CD4 counts in patients with AIDS.” Journal of the American Statistical Association, 90, 27-37.
[30] Tsiatis, A.A. and Davidian, M. (2001). “A semiparametric estimator for the proportional hazards model with longitudinal covariates measured with error.” Biometrika, 88, 446-458.
[31] Wang, Y. and Taylor, J.M.G. (2001). “Jointly Modeling Longitudinal and Event Time Data With Application to Acquired Immunodeficiency Syndrome.” J. Am. Statist. Assoc., 96, 895-905.
[32] Wulfsohn, M.S. and Tsiatis, A.A. (1997). “A Joint Model for Survival and Longitudinal Data Measured with Error.” Biometrics, 53, 330-339.
[33] Zeng, D. and Cai, J. (2005). “Asymptotic Results for Maximum Likelihood Estimators in Joint Analysis of Repeated Measurements and Survival Time.” The annals of Statistics, 33(5), 2132-2163.
|